Skip to main content
Have a personal or library account? Click to login
HDL and Reverse Cholesterol Transport Biomarkers Cover

HDL and Reverse Cholesterol Transport Biomarkers

Methodist DeBakey Cardiovascular Journal
Volume 15 (2019): Issue 1
By:  and    
Open Access
|Jan 2019
Figures & tables

Figures & Tables

Figure 1.

Measurement of high-density lipoproteins (HDL) and HDL function. (1) HDL cholesterol (HDL-C) concentration measurement via assay with centrifugation. (2) HDL particle (HDL-P) count measurement via nuclear magnetic resonance spectroscopy. (3) Cholesterol efflux capacity measures the movement of cholesterol.

Figure 2.

Association of extreme high-density lipoprotein cholesterol (HDL-C) values with mortality. Japanese cohort: Extremely low HDL-C: < 40 mg/dL; extremely high HDL-C ≥ 90 mg/dL. Danish cohort: Extremely low HDL-C: < 39 mg/dL; extremely high HDL-C: men ≥ 116 mg/dL, women ≥ 135 mg/dL.

Table 1.

Behavioral and therapeutic interventions that affect cholesterol efflux capacity. CETP: cholesteryl ester transfer protein; LDL: low-density lipoprotein; HDL: high-density lipoprotein

i1947-6094-15-1-39-t01.jpg
DOI: https://doi.org/10.14797/mdcj-15-1-39 | Journal eISSN: 1947-6108
Journal RSS Feed
Language: English
Page range: 39 - 46
Published on: Jan 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
high-density lipoprotein,
HDL,
cholesterol efflux capacity,
HDL-C,
HDL-P

© 2019 Kayla A. Riggs, Anand Rohatgi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 15 (2019): Issue 1
Previous article
Next article